ABSTRACT MiRNAs are a kind of non-coding RNA molecules found in plants, animals, and various viruses. They have been proved to play an important role in multiple biological as well as physiological processes. Specifically, a growing number of studies have shown that miRNAs have close relationships with many diseases, and thus the exploration of the relationships between miRNAs and diseases is of great significance in disease research. Although traditional experimental methods can obtain the associations between miRNAs and diseases, the amount of data obtained is far from enough for us to fully understand the associations between them. Besides, traditional experiments are generally time-consuming and expensive. Therefore, it is necessary to propose efficient computational methods to predict miRNA-disease associations. In this paper, we develop a novel computational method based on KATZ model to predict MiRNA-Disease Associations (KATZMDA) by integrating multiple data sources. To evaluate the performance of KATZMDA, four classical methods are used to compare with our methods (WBSMDA, HGIMDA, RKNNMDA, MCMDA). The experimental results demonstrate that our method can be used as an effective tool to identify diseaserelated miRNAs. In addition, case studies of three common diseases further verify the utility of our method.
I. INTRODUCTION
MiRNAs are a kind of non-coding RNA molecules which play an important role in multiple biological processes, including cell proliferation, differentiation, aging, development, apophasis and so on [1] . The discovery of the first miRNA (Lin-4) in the early 1990s opened the prelude to study miRNA [2] . During the past decades, over 20000 miRNA entries have been indexed by miRBase [3] . Studies have shown that miRNAs have close relationships with various complex human diseases, such as lung cancer, heart diseases and breast cancer [4] - [6] . Therefore, the exploration of the relationships between miRNAs and diseases will be of great significance to help us understand the molecular mechanisms of diseases.
Great efforts have been made to uncover the relationships between miRNAs and diseases by the traditional methods, such as PCR and microarray [7] . Generally, the experimental methods are time-consuming and only applicable to small-scale experimental data. Therefore, there is an urgent need to propose efficient computational methods to discover associations between miRNAs and disease on a large scale. In the past few years, a great many methods were proposed to predict the miRNA-disease associations. Based on the assumption that functionally related miRNAs tend to be associated with phenotypic similar diseases and vice versa [8] , Jiang et al. [9] proposed the first computational model based on hypergeometric distribution to predict miRNA-disease associations by building a heterogeneous network, which integrated the miRNA functional similarity network, disease phenotype similarity network and known phenome-microRNAome network. Xuan et al. [10] developed an effective method named HDMP to discover the relationships of miRNAs and diseases based on weighted k most similar neighbors. The miRNA functional similarity was calculated by integrating the similarity of information content of disease terms and phenotype similarity between diseases. Mørk et al. [11] presented an approach named miRPD to predict disease-related miRNAs. Known associations as well as predicted associations among miRNA, proteins and disease were first analyzed and then a scoring scheme was used to rank candidate miRNA-disease associations. In addition, it is considered that the global network similarity measures are better than local network similarity measures in predicting miRNA-disease associations [12] . RWRMDA is the first global network-based method to infer miRNA-disease associations [13] . It implemented random walk method on the miRNA functional similarity network and obtained favorable performance. As a matter of fact, the random walk has been widely used to predict the associations between miRNAs and diseases, and experimental results show that it can effectively predict disease related miRNAs. Recently, an algorithm BRWH based on unbalanced bi-random walk was proposed by Luo and Qiu [14] . Similarly, satisfactory performance was achieved. However, one limitation of RWR-MDA is that it could not identify novel disease-miRNA associations without any known related miRNAs. Subsequently, Chen et al. [15] proposed another method called WBSMDA, which calculates a final score for potential miRNA-disease associations by integrating miRNA functional similarity, disease semantic similarity, known miRNA-disease associations and Gaussian interaction profile kernel similarity of miRNAs and diseases. With the rapid development of bio-technology, more and more biological databases are established, which makes it feasible to integrate heterogeneous information from different databases to reliably predict the miRNA-disease associations. Lan et al. [16] presented an approach in which Kernelized Bayesian matrix factorization method is employed to infer potential miRNA disease association by integrating sequence and functional information of miRNA as well as semantic information of disease. Liu et al. [17] further extended Lan's method by using the miRNA-target gene and miRNA-lncRNA associations to calculate the miRNA similarity network. Shi et al. [18] first established a heterogeneous network by integrating multiply data sources including protein-protein interaction data, gene ontology data, experimentally verified miRNA-target relationships, disease phenotype information and known miRNA-disease connections, and they then predicted miRNA-disease associations by implementing RWR algorithm on the complex heterogeneous network. A collective method based on transduction learning was presented by Luo et al. [19] . Recently, Luo et al. [20] proposed a semi-supervised method named KRLSM to uncover the associations between miRNAs and disease. Machine learning has been a hot topic in recent years, some machine learning approaches can be utilized to solve this question. In general the goal of most methods is to propose a model to calculate the similarity of network [21] . Although the existing methods have made remarkable contributions, there is still room for the improvement of prediction accuracy [22] .
In this paper, we propose an effective approach named KATAMDA to infer potential associations between miRNAs and diseases. Our method is inspired by the KATZ model, which has been successfully applied to predict social associations in social networks [23] . Our model mainly consists of three steps: firstly, we calculate the similarity for miRNAs and diseases; secondly, we construct a heterogeneous network by integrating the similarity information; thirdly, we predict miRNA-disease associations based on KATZ. The experimental results demonstrate that our method can effectively discover potential miRNA-disease associations.
II. DATA AND KATZ METHOD A. HUMAN miRNA DISEASE ASSOCIATIONS NETWORK
The human miRNA disease associations are downloaded from the latest HMDD V2.0 which was released in 2013 [24] . HMDD is a database that curates experiments supported miRNA-disease associations. After filtering, 5430 associations between 383 diseases and 495 miRNAs were retained. For better understanding, we use an adjacency matrix A to describe the associations between miRNAs and diseases. Concretely, if miRNA i has been confirmed to be related to disease j, the association between them can be represented as A (i, j) = 1 , and A (i, j) = 0 otherwise.
B. MiRNA-miRNA SIMILARITY NETWORK
Assuming that functionally similar miRNAs tend to be associated with similar diseases, Wang et al. [25] proposed a method named MISIM for computing the functional similarity of miRNAs. We downloaded the functional scores directly from http://www.cuilab.cn/files/images/cuilab/misim.zip. Similarly, an adjacency matrix FS was used to indicate miRNA functional similarity scores. For example, the functional similarity score between miRNA i and j can be represented with FS (i, j).
C. DISEASE-DISEASE SIMILARITY NETWORK
The MeSH database provided a strict system for disease classification and is helpful for studying the relationship of diseases. Each disease can be described as a DAG (Directed Acyclic Graph), which consists of some nodes and links. Each node represents a disease while a link represents the relationship between two diseases. Disease A can be describe as a graph, DAG A = (A, T A , E A ) , where T A is the ancestor 3944 VOLUME 6, 2018 nodes or itself of A while E A is the set of corresponding links. The contribution of disease t in DAG A to the semantic value of disease A, D A (t) can be defined as follows:
Since disease A is the most specific disease, we define the contribution to itself is 1 and others are 0.5. Then, the semantic value of A, DV (A) can be defined as:
Therefore, the semantic similarity of disease A and disease B can be defined as follows:
Where D A (t) and D B (t) represent the value of disease t-related to disease A and disease B respectively. By iteratively calculating the semantic similarity for each disease pair, we can obtain a disease similarity matrix SS. We use SS (i, j) to represent the semantic similarity of disease i and j.
D. KATZ method
KATZ model was first applied to predict social associations in a social network, and it has also been successfully applied to predict lncRNA-disease associations, disease-gene associations as well as microbe-disease associations [26] - [28] . KATZ is a network-based computational method and it could calculate the correlation of nodes in the heterogeneous network. Generally, there are two factors need to be considered when calculating the correlation between miRNA i and disease j in the known miRNA-disease associations network(A): the number of walks between node i and node j and the difference in length between different walks. A l ij denotes the number of walks which links node i and node j. Then, in order to get a comprehensive association measure between miRNA i and disease j, we integrate all the walks that connect the two nodes. As a matter of fact, since the walks are different in length, the contribution of different walks to the calculation of the correlation between miRNAs and diseases is also different. A nonnegative parameter β is used to control the contribution of different walks. The shorter is the length, the bigger the contribution is. That is, if β 1 < β 2 , then l 1 > l 2 . Therefore, the associations between miRNA i and disease j can be calculated by:
All walks of the network can be described through
If l → ∞, β l → 0 . By replacing β l with β l , formula(5) can be written as:
Finally, we construct a heterogeneous network by integrating the miRNA functional similarity matrix, the disease semantic similarity matrix, and the known miRNA-disease associations. The adjacency matrix of the heterogeneous network can be denoted as:
Where FS represents the miRNA functional similarity matrix, SS represents the disease semantic similarity matrix, A represents the known miRNA-disease associations matrix. Next, we substitute the adjacent matrix A * for A in the formula(6) to obtain the final miRNA-disease associations. When k = 2, 3, 4, the expression can be written as follows
III. KATZMDA: THE PROPOSED APPROACH
The innovation of the proposed approach KATZMDA is that we calculate the miRNA similarity and disease similarity based on KATZ model, and then we integrate multiple data sources to construct a reliable heterogeneous network. At last, we predict miRNA-disease associations based on KATZ to obtain the final results. KATZMDA is simple and effective, which greatly cut down the necessary time of calculation, is of great significance for large-scale prediction of the relationships between miRNAs and diseases.
A. CALCULATION OF THE miRNA SIMILARITY AND DISEASE SIMILARITY
Most existing methods use the functional similarity to represent the similarity of miRNAs. However, we find that the similarity matrix is quite sparse. A majority of miRNAs have few links with others. The sparsity of the miRNA similarities might lead to errors in experimental results. Therefore, we apply KATZ to calculate a new miRNA similarity matrix (KM ). First, we derive a new miRNA-miRNA associations matrix (A m ) based on the miRNA functional similarity matrix (FS). Specifically, if miRNA i has a link with miRNA j, we set A m (i, j) = 1 . Otherwise, we set A m (i, j) = 0 . The miRNA-miRNA network is constructed by integrating the miRNA functional similarity (FS) and A m . The network can then be represented as follows:
Next, we substitute M into the formula (6) to obtain the new miRNA similarity matrix KM . Since he disease VOLUME 6, 2018 sematic similarity DS is also sparse, we use the same method to obtain a new disease-disease associations matrix (A d ). We integrateA d and FS to get the disease-disease network. It could be represented as follows:
Similarly, we substitute D into the formula (6) to obtain the new disease similarity matrix (KD).
B. INTEGRATION OF DATA TO CONSTRUCT A HETEROGENEOUS NETWORK
In the previous section, we have obtained KM and KD which are used to combine with FS and SS respectively. For miRNA i and j, if FS (i, j) = 0 , we have in the final miRNA similarity
. Similarly, we apply the same way to obtain a new integrated disease similarity matrix DS, by integrating KD and SS. Finally, the formulas can be presented as:
We integrate the data of MS, DS with the known miRNA-disease associations. The adjacent matrix of the heterogeneous network can be denoted as:
Where MS represents the integrated miRNA similarity matrix, DS represents the integrated disease similarity matrix, and A represents the known miRNA-disease associations matrix.
Same as previous work, we substitute the adjacent matrix A * into the formula (6) to obtain the final miRNAdisease associations.
IV. EXPERIMENTAL RESULTS
In this section, we use LOOCV (leave one out cross validation), 2-fold cross-validation and 5-fold crossvalidation to evaluate the performance of each method respectively. Firstly, we compare our method with KATZ method. Secondly, we compare the performance of four classical methods with that of our method. Thirdly, we carry our case studies of three common diseases to further verified the performance of our method.
A. LEAVE ONE OUT CROSS VALIDATION
For the leave-one-out cross validation, each known association is left out in turn as the test sample and the rest of the associations are regarded as training samples. Here, all miRNA-disease pairs that do not have known evidence are treated as candidate samples. Therefore, this process is repeated 5430 times in total for all the known miRNA-disease associations. At each iteration, a ranking is obtained for the test samples. If the ranking is higher than a given threshold, the prediction is regarded as a successful prediction. The higher the ranking is, the better the performance will be. After each process, FPR (false positive rates) and TPR (true positive rates) can be obtained to draw the receiver-operating characteristics (ROC) curves by setting different thresholds and then the predictive accuracy can be measured by AUC (Area Under roc Curve). AUC is a standard measurement of accuracy for a classification model. The higher the AUC value is, the better the performance is.
B. K -FOLD CROSS-VALIDATION
In k-fold cross-validation, we divide all the known associations of a given disease into k equal sized subsets. One of them is retained as the validation data for testing the model while the remaining datasets are regarded as training data. In order to get more accurate experimental results, we repeated the process several times, taking the average of the results as the final result. In this paper, 2-fold cross-validation and 5-fold cross-validation are used to evaluate the predictive performance of KATZMDA.
C. EFFECTS OF PARAMETERS
KATZMDA has two parameters β and k. Nonnegative parameter β is used to control the contribution of different walks. β is chosen on the basis of β < 1/ A 2 . The choice of k represents the number of walks for KATZ and it has a very large effect on the experimental results. When calculating the disease similarity, the miRNA similarity and predicting the miRNA-disease associations, we use k 1 , k 2 and k 3 to represent the value of k respectively. To select an appropriate value for these three parameters, we compare the experimental results by using LOOCV by setting each of the values of k 1 , k 2 and k 3 to 2, 3 and 4 respectively. As shown in figure 2, when k 1 = 2, k 2 = 4, k 3 = 2, we obtain the best results.
D. COMPARISON WITH OTHER METHODS
The innovation of our method is that we first use KATZ model to compute the similarity matrix of miRNA and the similarity matrix of diseases, and then combine them with the original FS and SS to obtain two new similarity matrices (MS, DS). A heterogeneous network is obtained by integrating MS, DS and known miRNA-disease associations network. Next, we add the corresponding adjacency matrix (formula 12) of the heterogeneous network into formula (6) to obtain the final prediction results. According to Zou's method, we add the original adjacency matrix (formula 7) into formula (6) to test the prediction performance. We compare the two methods through LOOCV, 2-fold cross validation and 5-fold cross validation respectively. The final results can be seen in Figure 3 . As shown in Figure 3 , our method can obtain better prediction accuracy than KATZ.
To verify whether our method is effective in predicting the potential relationships between miRNAs and diseases, we select four classical methods, i.e. WBSMDA [15] , HGIMDA [29] , RKNNMDA [30] , MCMDA [31] and 0.9028 respectively. Obviously, our method has superior performance over these methods.
To further verify the predictive performance of the model, Breast Neoplasms, Lung Neoplasms and Lymphoma are selected for case studies. PhenomiR2.0 [32] and dbDEMC 2.0 [33] are regarded as the gold-standard datasets when evaluating the predicted results. Moreover, we downloaded the corresponding miRNA expression profiles for the three diseases from The Cancer Genome Altas (TCGA, https://cancergenome.nih.gov/) using R package TCGAbiolinks, and performed differential analysis with R package edgeR to validate whether the predicted disease-related miRNAs are also differentially expressed between tumor and normal samples. Since there are only tumor samples for Lymphoma in TCGA, we carried out our analysis on Breast Neoplasms and Lung Neoplasms. For Breast Neoplasms, the Breast Invasive Carcinoma (BRCA) from TCGA was used. For Lung Neoplasms, both Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC) are used and the differentially expressed miRNAs detected from each disease are merged together. miRNAs with absolute log foldchanges > 1 and adjusted p-value < 0.01 are considered as differentially expressed.
Breast Neoplasms is fairly a common disease that happens to women in general, and leads to many deaths every year [34] . We list the top 50 candidate miRNAs of Breast Neoplasms predicted by our method in Table 1 and find that all of the top 50 listed candidate miRNAs have been verified to be related to Breast Neoplasms by aforementioned databases. Furthermore, we found that 15 out of the top 50 candidate miRNAs are also differentially expressed.
Specifically, 3 differentially expressed miRNAs hsa-mir-92b, hsa-mir-192 and hsa-mir-32 are in the top 10 predicted candidate miRNAs.
Lung Neoplasms is also one of the most common diseases killing a million people worldwide every year. Using the same method, we take the top 50 candidate miRNAs and analyze whether they are associated with lung Neoplasms. Table 2 presents the results of prediction potential miRNAs of Lung Neoplasms. The results further confirm that our approach is a very effective method. As shown in Table 2 , we find that 48 out of them have been confirmed, and only 2 miRNAs are left as unconfirmed. Besides, 23 out of the top 50 candidate miRNAs are also differentially expressed. Specifically, 5 differentially expressed miRNAs hsa-mir-429, hsa-mir-141, hsa-mir-20b, hsa-mir-296 and hsa-mir-520b are in the top 10 predicted candidate miRNAs. Moreover, we found that the predicted unconfirmed miRNA hsa-mir-520c is actually significantly differentially expressed in both LUAD (log fold-change = 3.31, adjusted p-value < 10 −2 ) and LUSC (log fold-change = 5.37, adjusted p-value < 10 −5 ), which provides a solid evidence for its association with lung neoplasms.
We also analyze another disease, Lymphoma, which is a common disease that threatens human life and health in the world. Notably, we find that 48 candidate miRNAs have been confirmed according to the mentioned databases (Table 3) . Taken together, the case studies of the three diseases further verify the utility of our method in uncovering the potential miRNA-disease associations.
V. CONCLUSION
An increasing number of studies have shown that miRNAs play important roles in various biological processes. Consequently, the identification of the relationships between miRNAs and diseases is of great significance. Although experimental methods can identify their relationships, these methods are usually time consuming and only applicable to small-scale datasets. Therefore, it is imperative to propose effective approach to predict the underlying relationships between miRNAs and diseases. In this paper, we propose a novel method based on KATZ model to predict the relationship between miRNA and the disease. Our method could be used to calculate both miRNA similarity matrix and disease similarity matrix. To evaluate the prediction performance, we compare our method with four other alternatives by leave one out cross-validation and k-fold cross-validation. In addition, three specific diseases are used to further demonstrate the predictive performance of the model. Experiments show that our model has superior performance over other existing methods and is effective for predicting miRNA-disease associations. Although our method can predict miRNA-disease associations effectively, there are still some limitations need to be addressed, since we only use a single dataset to calculate the similarity matrix for miRNA and diseases. Moreover, although our approach can be used as a tool for predicting miRNA-disease associations, the prediction accuracy needs to be further improved. In the following study, we will integrate multiple data sources into our approach to improve the prediction accuracy.
